Skip to main content
TBPH logo

TBPH · Theravance Biopharma, Inc.

$16.94 +0.04 (+0.21%)
Market Cap
$871.25M
Shares
51.55M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Pick a completed quarter in the Quarter selector below to see a single quarter with position changes.
Holders: 180
Total Value: $786,025,291
Total Shares: 50,232,559
Showing 1–100 of 187 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 173 13F filers
Top Holder
19.6%
Jun 2023 → Mar 2026 · range 16.7% – 21.8%
of institutional value
Top 5
59.5%
Jun 2023 → Mar 2026 · range 58.3% – 64.6%
of institutional value
Top 10
72.8%
Jun 2023 → Mar 2026 · range 72.1% – 80.7%
of institutional value
HHI
888
Jun 2023 → Mar 2026 · range 864 – 1,070
Broadly held
Showing 100 of 187
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1583107 CUSIP G8807B106 13F (30d) 37 filings 37 filers Visit website Investor relations